Roche Holding Ltd ADR (RHHBY OTCQX) stock market data APIs
$51.9274
0.58(1.1%)
as of July 10, 2026
Try our APIs with
free plan!
Roche Holding Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
51.9274
Open
52.5106
High
52.7733
Low
51.505
52 wk Range
36.3593-58.9834
Market Cap
334 282 M
P/E Ratio
20.9274
Shares Outstanding
5 511 M
Revenue
63 356 M
EPS
0
Dividends (Yield)
0.0299
Beta
0.344
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding Ltd ADR data using free add-ons & libraries
Get Roche Holding Ltd ADR Fundamental Data
Roche Holding Ltd ADR Fundamental data includes:
- Net Revenue: 63 356 M
- EBITDA: 24 044 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-04-23
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding Ltd ADR News
New
Should You Buy Eli Lilly Stock? Here's My Honest Take.
Key Points Lilly's business is booming. However, there is a bear case against the pharma stock. One smart strategy could be to gradually build a position in Lilly.10 stocks we like better than Eli Li...
Reasons Why Investors Should Consider Betting on PTC Stock Now
PTC Therapeutics PTCT has built a diversified global commercial portfolio across multiple rare disease indications, providing a strong foundation for sustainable revenue growth. Sephience: PTCT's Maj...
Ionis extends losses as Roche scraps two partnered studies
[Roche Diagnostics campus facade in Silicon Valley] Michael Vi/iStock Editorial via Getty Images Shares of Ionis Pharmaceuticals (IONS [https://seekingalpha.com/symbol/IONS]) continued to trade lower...
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Nurix Therapeutics, Inc. Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co...
Get Roche Holding Ltd ADR fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
